Cash Flow Statement Analysis - Pfizer Inc.

Pfizer Inc. has provided the following information from its cash flow statement for the fiscal year ended December 31, 2023:

• Cash Flow from Operating Activities: $30,000 million
• Cash Flow from Investing Activities: ($20,000) million
• Cash Flow from Financing Activities: $15,000 million

Calculate the net change in cash for Pfizer Inc. for the year ended December 31, 2023.